Home About Us Writing a Scientific Article Author's Instruction Contact us



/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /


October 2017 Vol. 5 No.10

Other viewing option

• Full text
Reprint (PDF) (793 KB)

Search Pubmed for articles by:

Alghamdy AH
El-Refaei MF

Other links:
PubMed Citation
Related articles in PubMed



Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 5(10) pp. 519-528, October, 2017 

Copyright © 2017 Merit Research Journals

Original Research Article

Protective Effects of Caffeic Acid Phenethyl Ester on Type 1 Diabetes: Impact of Metalloproteinase and Angiogenic Inhibitor on Hyperglycemia in Vivo


Ahmed H. Alghamdy1 and Mohamed F. El-Refaei2*


1Department of Pediatric, Faculty of Medicine Albaha University, Saudi Arabia
2Molecular Biology Department, Institute of Genetic Engineering and Biotechnology, Sadat City University, Sadat City, Egypt

*Corresponding Author’s E-mail: melrefaei2000@yahoo.com

Accepted October 21, 2017




Type 1 diabetes (T1D) is a syndrome that upsurges the autoimmune destruction of insulin-producing pancreatic β cells. This study aims at investigating the potential and protective role of caffeic acid phenethyl ester (CAPE) on T1D experimental model. Swiss mice were assigned into three groups of eight mice/group. Group 1 mice were normal; Groups 2 is induced diabetic mice by administration of cyclosporin/STZ and group 3 is a diabetic mice treated with CAPE6 µM/kg. Mice group 2 showed marked increases in blood glucose levels. As regard to glycogen hepatic content, a 35.3% reduction was observed in the induced diabetic group 2, this reduction improved to 1.5% in treated group 3. Consequently, a significant elevation of SOD, GSH, and CAT enzymes were seen in the treated group compared to untreated. In addition, serum MMP-9 significantly reduced and TMP-1 appeared to have significantly increased in the treated group compared with untreated. Furthermore, histopathological examination showed marked regenerative changes and normal architecture of islet cell in the treated group compared with untreated once. CAPE has antidiabetic properties related to their anti-inflammatory and angiogenic inhibitor activation effects and may be relevant in the future for human diabetic therapy.

Keywords: Diabetes, Antioxidant enzymes, CAPE, Angiogenesis, Angiogenic inhibitor






Merit Research Journals© 2017 || Advertisement | Privacy policy.